Shockwave C2 Shocks the Coronary Arterial Disease Device Market

With Shockwave surpassing Wall Street’s expectations with their third-quarter earnings, Guidepoint Qsight took a closer look at how their new C2 catheter has taken the Coronary Arterial Disease Device market by storm.

  • In February 2021, Shockwave launched its C2 Coronary Intravascular Lithotripsy catheter, which is a device that helps open up calcified arteries to allow for stent implantation.
  • Shockwave’s C2 rapidly captured significant market spend and unit share in the coronary arterial device market just eight months after its launch.
  • When taking a closer look, Qsight’s healthcare facilities purchasing dataset found that C2 is priced at a premium compared to competing brands. 
  • Although Boston Scientific’s ROTAPRO Atherectomy System has been purchased by the greatest number of healthcare facilities, Qsight’s dataset shows that Shockwave’s C2 catheter increased market penetration from 12% to 50% in just eight months after its introduction to the market.
  • Shockwave’s explosive gain in share is due to Shockwave’s C2 higher price point and a result of rapid market acceptance and adopted use.
  • The question remains if Shockwave can continue this momentum and remain a market leader, stealing more share from legacy brands in the coronary arterial device market. 

The above is based on Qsight’s healthcare facilities purchasing dataset analyzing over $150M from the four dominant players in the U.S. coronary arterial device market across a panel of 600+ distinct healthcare facilities and hospitals. 

To access more information and insights like the ones above, request a demo here.

Post Created by Shimul Sheth, Senior Quantitative Analyst, Guidepoint Qsight, and Kenneth Dolgin, Vice President of Quantitative Research, Guidepoint Qsight

Leave a comment

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.